• Return to Headlines

Osiris Therapeutics Shares Up 48.4% Since SmarTrend's Buy Recommendation (OSIR)

By Amy Schwartz

SmarTrend identified an Uptrend for Osiris Therapeutics (NASDAQ:OSIR) on March 23rd, 2017 at $4.00. In approximately 2 months, Osiris Therapeutics has returned 48.36% as of today's recent price of $5.93.

Osiris Therapeutics share prices have moved between a 52-week high of $27.40 and a 52-week low of $2.67 and are now trading 122% above that low price at $5.93 per share. Over the past week, the 200-day moving average (MA) has gone down 2.8% while the 50-day MA has declined 2.7%.

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Osiris Therapeutics shares.

Log in and add Osiris Therapeutics (OSIR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights osiris therapeutics

Ticker(s): OSIR